Back-propagation artificial neural network and attenuated total reflectance-Fourier transform infrared spectroscopy for diagnosis of basal cell carcinoma by blood sample analysis

Journal of Chemometrics

Volumn 23, Issue 10, 2009, Pages 538-544

  Khanmohammadi, Mohammadreza ^a   Garmarudi, Amir Bagheri ^a,b   Ghasemi, Keyvan ^a  

^a IMAM KHOMEINI INTERNATIONAL UNIVERSITY   (Iran)

^b Engineering Research Institute   (Iran)

Author keywords

ATR FTIR spectroscopy; Blood; BP ANN; Classification; Diagnosis; Skin cancer

Indexed keywords

BACKPROPAGATION; BLOOD; CLASSIFICATION (OF INFORMATION); COMPUTER AIDED DIAGNOSIS; DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; REFLECTION; SPECTROSCOPIC ANALYSIS; SPECTRUM ANALYSIS; SUPERSATURATION;

ATTENUATED TOTAL REFLECTANCE FOURIER TRANSFORM INFRARED SPECTROSCOPY; BACK PROPAGATION; BACK-PROPAGATION ARTIFICIAL NEURAL NETWORK; BASAL CELL CARCINOMA; BLOOD; BLOOD SAMPLES; DIAGNOSTIC METHODS; INFRARED SPECTRUM; SAMPLE ANALYSIS; SKIN CANCERS;

NEURAL NETWORKS;

EID: 70350367128     PISSN: 08869383     EISSN: 1099128X     Source Type: Journal    
DOI: 10.1002/cem.1250     Document Type: Article

References (48)

1. Lasch P, Wasche W, McCarthy WJ, Muller G, Naumann D. Imaging of human colon carcinoma thin sections by FT-IR micro spectrometry. Cell Mol. Biol. 1998; 44: 189-201.
2. Argov S, Ramesh J, Salman A, Sinelnikov I, Goldstein J, Guterman H, Mordechai S. Diagnostic potential of Fourier-transform infrared micro spectroscopy and advanced computational methods in colon cancer patients. J. Biomed. Opt. 2002; 7: 1-5.
3. Ramesh J, Salman A, Argov S, Goldstein J, Sinelnikov I, Walfisch S, Guterman H. FTIR microscopic studies on normal, polyp, and malignant human colonic tissues. Subsurf. Sens. Technol. Appl. 2001; 2: 99-112.
4. Salman A, Argov S, Shau RK, Bernshtain E, Walfisch S, Mordechai S. Probing cell proliferation in the human colon using vibrational spectroscopy: a novel use of FTIR-microspectroscopy. Vib. Spectrosc. 2004; 34: 301-308.
5. Cohenford MA, Rigas B. Cytologically normal cells from neoplastic cervical samples display extensive structural abnormalities on IR spectroscopy: implications for tumor biology. Proc. Natl Acad. Sci. U.S.A. 1998; 95: 15327-15332.
6. Argov S, Sahu RK, Bernshtain E, Salman A, Shohat G, Zelig U, Mordechai S. Inflammatory bowel diseases as an intermediate stage between normal and cancer: a FTIR- microspectroscopy approach. Biopolymers 2004; 75: 384-392.
7. Fujioka N, Morimoto Y, Arai T, Kikuchi M. Discrimination between normal and malignant human gastric tissues by Fourier-transform infrared spectroscopy. Cancer Detect. Prev. 2004; 28: 32-36.
8. Edwards EA, Duntley SQ. The pigments and colour of living human skin. Am. J. Anat. 1939; 65: 1-33.
9. Khanmohammadi M, Ansari MA, Bagheri Garmarudi A, Hassanzadeh G, Garoosi G. Cancer diagnosis by discrimination between normal and malignant human blood samples using Attenuated Total Reflectance-Fourier transform infrared spectroscopy. Cancer Invest. 2007; 25: 397-404.
10. Khanmohammadi M, Nasiri R, Ghasemi K, Samani S, Bagheri Garmar- udi A. Diagnosis of basal cell carcinoma by infrared spectroscopy of whole blood samples applying soft independent modeling class analogy. J. Cancer Res. Clin. 2007; 133: 1001-1010.
11. Shaw RA, Leroux M, Paraskevas M, Guijon FB, Kotowich S, Mantsch HH. Discrimination and quantitation using IR spectra: novel methods for serum analysis and for servical dysplasia screening. In Infrared Spectroscopy: New Tool in medicine, Vol. 3257, Mantsch HH, Jackson M (eds). SPIE: Washington, DC, 1998; 42-50.
12. Werner GH, Fruh J, Keller F, et al. Mid-infrared spectroscopy as tool for disease pattern recognition from human blood. In Infrared Spectroscopy: New Tool in medicine, Vol. 3257, Mantsch HH, Jackson M (eds). SPIE: Washington, DC, 1998; 35-41.
13. Berger AJ, Koo TW, Itzkan I, Horowitz G, Feld MS. Multicomponent blood analysis by near-infrared Raman spectroscopy. Appl. Opt. 1999; 38: 2916-2926.
14. Cooley WW, Lohnes RP. Multivariate Data Analysis. John Wiley & Sons, Inc.: New York, 1971.
15. Morrison DF. Multivariate Statistical Methods. McGraw-Hill Inter- national: Auckland, 1978.
16. Mardia KV, Kent JT, Bibby JM. Multivariate Analysis. Academic Press: London, 1989.
17. Deming SN, Morgan SL. Experimental Design: A Chemometric Approach. Elsevier: Amsterdam, 1993.
18. Wackernagel H. Multivariate Geostatistic: An Introduction with Application, 3rd edn. Springer: Heidelberg, 2003.
19. Brereton RG. Chemometrics. John Wiley & Sons: London, 2003.
20. Zupan J, Gasteiger J. Neural Networks for Chemists. VCH: Weinheim, 1993.
21. Luinge HJ, Leussink ED, Visser T. Trace-level identity confirmation from infrared spectra by library searching and artificial neural networks. Anal. Chim. Acta 1997; 345: 173-184.
22. Penchev PN, Andreev GN, Varmuza K. Automatic classification of infrared spectra using a set of improved expert-based features. Anal. Chim. Acta 1999; 388: 145-159.
23. Clevaa C, Cacheta C, Cabrol-Bassa D, Forrest TP. Advantages of a hierarchical system of neural-networks for the interpretation of infrared spectra in structure determination. Anal. Chim. Acta 1997; 348: 255-265.
24. Eghbaldar A, Forrest TP, Cabrol-Bass D. Development of neural net- works for identification of structural features from mass spectral data. Anal. Chim. Acta 1998; 359: 283-301.
25. McIntosh LM, Jackson M, Mantsch HH, Stranc MF, Pilavdzic D, Crowson AN. Infrared spectra of basal cell carcinomas are distinct from non- tumor-bearing skin components. J. Invest. Dermatol. 1999; 112: 951-956.
26. Wong PT, Goldstein SM, Grekin RC, Godwin TA, Pivik C, Rigas B. Distinct infrared spectroscopic patterns of human basal cell carcinoma of the skin. Cancer Res. 1993; 53: 762-765.
27. Gniadecka M, Wulf HC, Mortensen NN, Nielsen OF, Christensen DH. Diagnosis of basal cell carcinoma by Raman spectroscopy. J. Raman Spectrosc. 1997; 28: 125-129.
28. Montesano R, Hainaut P, Hall J. The use of biomarkers to study pathogenesis and mechanisms of cancer: oesophagus and skin cancer as models. IARC Sci. Publ. 1997; 142: 291-301.
29. Dore ́ JF, Pedeux R, Boniol M, Chignol MC, Autier P. Intermediate-effect biomarkers in prevention of skin cancer. IARC Sci. Publ. 2001; 154: 81-91.
30. Barbareschi M, Girlando S, Cristofolini P, Cristofolini M, Togni R, Boi S. p53 protein expression in basal cell carcinomas. Histopathology 1992; 21: 579-581.
31. Salomatina EV, Jiang B, Novak J, Yaroslavsky AN. Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range. J. Biomed. Opt. 2006; 11: 064026-064034.
32. McIntosh LM, Jackson M, Mantsch HH, Mansfield JR, Crowson AN, Toole JWP. Near-infrared spectroscopy for dermatological applications. Vib. Spectrosc. 2002; 28: 53-58.
33. D'Errico M, Calcagnile AS, Corona R, Fucci M, Annessi G, Baliva G, Tosti ME, Pasquini P, Dogliotti E. p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res. 1997; 57: 747-752.
34. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP. Overexpression of p53 protein in basal cell carcinomas of human skin. Am. J. Pathol. 1992; 141: 25-29.
35. Calli Demirkan N, Colakoglu N, Duzcan E. Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas. Pathol. Oncol. Res. 2000; 6: 272-274.
36. Yan L, Chen M, Yu G. Expression of bcl-2, bax and p53 protein in the basal cell carcinoma. Hunan Yike Daxue Xuebao. 1999; 24: 179-180.
37. Cazal C, Ely MR, Sobral APV, Padilha DDN. Increase of bcl-2 protein expression in aggressive basal cell carcinoma of head and neck. Pesqui. Bras. Odontopediatria Cli{dotless} ́n. Integr. 2006; 6: 267-272.
38. Wang WJ, Huang JY, Wong CK, Chang YT. A study of secondary cutaneous amyloidosis in basal cell carcinoma in Chinese patients: lack of correlation with bcl-2 or p53 protein expression. Arch. Dermatol. Res. 2000; 292: 379-383.
39. Krekels GAM, Verhaegh MEJM, Wagenaar SS, Ramaekers FCS, Neu- mann HAM. Keratins (K8 and K19) as potential markers of recurrent basal cell carcinoma. Eur. J. Dermatol. 1997; 7: 158-160.
40. Ristich VL, Bowman PH, Dodd ME, Bollag WB. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br. J. Dermatol. 2006; 154: 586-593.
41. Coulombe PA. Keratin Proteins and Non-Melanoma Skin Tumors. A research granted by National Cancer Institute (CA123530). Johns Hop- kins University: Baltimore, USA, 2007.
42. Habets JM, Tank B, Vuzevski VD, Brevé J, Van der Kwast T, Van Joost T. Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma. Anticancer Res. 1989; 9: 65-70.
43. Pavia DL, Lampman GM, Kriz GS. Introduction to Spectroscopy. SGS Series: Philadelphia, 1996.
44. Flury B, Riedwyl H. Multivariate Statistics-A Practical Approach. Chapman & Hall: London, 1988.
45. Hornik K, Stinchcombe M, White H. Multilayer feedforward networks are universal approximators. Neural Netw. 1989; 2: 359-366.
46. Hagan MT, Demuth HB, Beale MH. Neural Network Design. PWS Publishing: Boston, MA, 1996.
47. Fletcher R. Practical Methods of Optimisation, Vol. 1: Unconstrained Optimization. John Wiley & Sons, Inc.: New York, 1980.
48. Pearl J, Russell S. Bayesian networks. In Handbook of Brain Theory and Neural Networks, Arbib MA (ed.). MIT Press: Cambridge, MA, 2003; 157-160.